Nephrology Dialysis Transplantation, Vol 12, Issue 10 2166-2168, Copyright © 1997 by Oxford University Press
C Ozener, R Kiris, R Lawrence, Y Ilker and E Akoglu
Keywords: retroperitoneal fibrosis; tamoxifen;
hydronephrosis
CASE REPORTS
Potential beneficial effect of tamoxifen in retroperitoneal fibrosis
Division of Nephrology, and Department of Urology, Marmara, University Hospital, Istanbul, Turkey; Corresponding author at: Ismail Pasa sok No 50, Kosuyolu, Kadikoy, Istanbul, Turkey
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. F.H. van Bommel, T. R. Hendriksz, A. W.L.C. Huiskes, and A. G.M. Zeegers Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis Ann Intern Med, January 17, 2006; 144(2): 101 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Jois, K. Gaffney, T. Marshall, and D. G. I. Scott Chronic periaortitis Rheumatology, November 1, 2004; 43(11): 1441 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Evrenkaya, E. M. Atasoyu, S. Unver, C. Basekim, H. Baloglu, and M. Y. Tulbek Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2423 - 2424. [Full Text] [PDF] |
||||


